Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Chloride | HCID 5234 | — |
| Reactant | Cholesterol | HCID 5997 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 1,3-Oxathiolane-2-methanol, 2-benzoate | HCID 11064076 | — |
| Reactant | Phosphoric acid phosphate | HCID 21872022 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | HCID 46244897 | HCID 46244897 | — |
| Product | 1,3-Oxathiolane-2-methanol, 2-benzoate, (2R)- | HCID 46928042 | — |
Reaction Steps
(+/−)-2-(Benzoyloxymethyl)-1,3-oxathiolane (0.71 mmol, 160 mg) was dissolved in acetonitrile (0.6 mL) in a 25-mL round-bottomed flask. A 0.1 M phosphoric acid-phosphate buffer solution (15 mL) adjusted to pH 7.0 was added to the reaction followed by 21 units of cholesterol esterase from bovine pancreas (Sigma #C3766). The reaction was stirred at approximately 4° C. for a period of up to 24 h while maintaining the pH of the reaction media at pH 7.0 with 1 M sodium hydroxide solution. The progress of the reaction may be monitored by gas chromatography for disappearance of the (+/)-2-(benzoyloxymethyl)-1,3-oxathiolane and/or by chiral HPLC for enantiomeric enrichment. When the reaction had proceeded to about 50% conversion, the mixture was saturated with sodium chloride and extracted with methyl tert-butyl ether (5×5 mL). Concentration of the extracts afforded a crude product that was purified by silica gel chromatography to give 2(R)-(benzoyloxymethyl)-1,3-oxathiolane (68 mg) and 2(S)-(hydroxymethyl)-1,3-oxathiolane (38 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08153416B2 |
|---|
| Source dataset | uspto-grants-2012_04 |
|---|
| ORD ID | ord-3116738c12dc4eca8c53481f288dc7b9 |
|---|
| Source note | uspto-grants-2012_04 |
|---|